HUP0402036A2 - Protein tirozin-kináz inhibitorokkal bevont vagy impregnált vaszkuláris stent vagy graft és eljárás alkalmazására - Google Patents
Protein tirozin-kináz inhibitorokkal bevont vagy impregnált vaszkuláris stent vagy graft és eljárás alkalmazásáraInfo
- Publication number
- HUP0402036A2 HUP0402036A2 HU0402036A HUP0402036A HUP0402036A2 HU P0402036 A2 HUP0402036 A2 HU P0402036A2 HU 0402036 A HU0402036 A HU 0402036A HU P0402036 A HUP0402036 A HU P0402036A HU P0402036 A2 HUP0402036 A2 HU P0402036A2
- Authority
- HU
- Hungary
- Prior art keywords
- tyrosine kinase
- protein tyrosine
- impregnated
- vascular
- same
- Prior art date
Links
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title abstract 3
- 230000002792 vascular Effects 0.000 title abstract 3
- 210000001367 artery Anatomy 0.000 abstract 2
- 210000004204 blood vessel Anatomy 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 210000003462 vein Anatomy 0.000 abstract 2
- 206010052664 Vascular shunt Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
A találmány tárgya véredények stentelésére szolgáló eszköz, példáulegy kardiovaszkuláris stent, autológ véna/artéria graft, protetikusvéna/artéria graft, érkatéter vagy érsönt, mely egy protein tirozin-kináz inhibitorral van bevonva, adszorbeálva, impregnálva, vagy azkovalensen vagy ionosan kötődik hozzá. A protein tirozin-kinázinhibitor meggátolja az ér simaizomsejtek proliferációját a véredényegy olyan területén, mely közvetlenül szomszédos a fenti eszközzelés/vagy annak közelében helyezkedik el, míg az ér intimasejtekproliferációját ezzel egyidejűleg nem gátolja. A találmány a fentieszköz alkalmazására vonatkozó eljárást is ismerteti. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34373201P | 2001-10-25 | 2001-10-25 | |
PCT/US2002/034344 WO2003034938A2 (en) | 2001-10-25 | 2002-10-25 | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402036A2 true HUP0402036A2 (hu) | 2005-02-28 |
HUP0402036A3 HUP0402036A3 (en) | 2008-04-28 |
Family
ID=23347387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402036A HUP0402036A3 (en) | 2001-10-25 | 2002-10-25 | Vascular stent or graft coated or impregnated with protein tyrosine kinase inhibitors and method of using same |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040044405A1 (hu) |
EP (1) | EP1441749A4 (hu) |
JP (1) | JP2006519623A (hu) |
KR (1) | KR20040051618A (hu) |
CN (1) | CN1635858A (hu) |
BR (1) | BR0213497A (hu) |
CA (1) | CA2464093A1 (hu) |
CO (1) | CO5580792A2 (hu) |
EC (1) | ECSP045085A (hu) |
HU (1) | HUP0402036A3 (hu) |
IL (1) | IL161583A0 (hu) |
MX (1) | MXPA04003906A (hu) |
NO (1) | NO20042133L (hu) |
NZ (1) | NZ532593A (hu) |
PL (1) | PL374315A1 (hu) |
RU (1) | RU2004116068A (hu) |
WO (1) | WO2003034938A2 (hu) |
ZA (1) | ZA200403184B (hu) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050261283A1 (en) * | 2002-05-13 | 2005-11-24 | Vikas Sukhatme | Methods and compositions for the treatment of graft failure |
US7238198B2 (en) | 2002-06-26 | 2007-07-03 | Cook Incorporated | Stent-graft fastening |
US20050214343A1 (en) * | 2002-07-18 | 2005-09-29 | Patrice Tremble | Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis |
US20060240014A1 (en) * | 2003-06-03 | 2006-10-26 | Beth Israel Deaconess Medical Center | Methods and compounds for the treatment of vascular stenosis |
WO2005095641A1 (en) * | 2004-03-03 | 2005-10-13 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11) |
JP2007537153A (ja) * | 2004-03-05 | 2007-12-20 | リジェナークス・バイオファーマスーティカルズ・インコーポレイテッド | 細胞外基質蓄積の治療または防止 |
MX2007001155A (es) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1. |
WO2007033152A2 (en) * | 2005-09-12 | 2007-03-22 | Conor Medsystems, Inc. | Composition, system and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
US20070196428A1 (en) | 2006-02-17 | 2007-08-23 | Thierry Glauser | Nitric oxide generating medical devices |
JP5110559B2 (ja) * | 2006-11-24 | 2012-12-26 | 学校法人近畿大学 | 被覆ステント |
TW200940527A (en) | 2007-12-07 | 2009-10-01 | Vertex Pharma | Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea |
US9126025B2 (en) * | 2008-05-01 | 2015-09-08 | Bayer Intellectual Property Gmbh | Method of coating a folded catheter balloon |
EP2396303A2 (en) | 2009-02-13 | 2011-12-21 | Vertex Pharmaceuticals Incorporated | Solid forms of 2-(2, 4-difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide |
US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
AU2010249558A1 (en) * | 2009-05-20 | 2011-12-08 | Arsenal Medical, Inc. | Medical implant |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
US8372133B2 (en) * | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
SG191927A1 (en) | 2011-01-14 | 2013-08-30 | Vertex Pharma | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
KR101897952B1 (ko) | 2011-01-14 | 2018-09-12 | 스페로 트리넴, 인코포레이티드 | 피리미딘 자이라제 및 토포이소머라제 iv 억제제 |
US9187953B2 (en) | 2011-03-23 | 2015-11-17 | Rytec Corporation | Side column configuration for overhead roll-up door assemblies |
ES2576298T3 (es) | 2011-06-20 | 2016-07-06 | Vertex Pharmaceuticals Incorporated | Ésteres de fosfato de inhibidores de girasa y topoisomerasa |
US9326951B2 (en) | 2011-06-28 | 2016-05-03 | Yale University | Cell-free tissue engineered vascular grafts |
WO2014015105A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
EP3057953B1 (en) | 2013-10-17 | 2018-08-15 | Vertex Pharmaceuticals Incorporated | Co-crystals of (s)-n-methyl-8-(1-((2'-methyl-[4,5'-bipyrimidin]-6-yl)amino)propan-2-yl)quinoline-4-carboxamide and deuterated derivatives thereof as dna-pk inhibitors |
US11541149B2 (en) | 2015-12-11 | 2023-01-03 | Research Institute At Nationwide Children's Hospital | Systems and methods for optimized patient specific tissue engineering vascular grafts |
WO2018102074A1 (en) * | 2016-11-04 | 2018-06-07 | University Of Delaware | Method for protecting skeletonized blood vessels |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4824436A (en) * | 1985-04-09 | 1989-04-25 | Harvey Wolinsky | Method for the prevention of restenosis |
US5171217A (en) * | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
US6306421B1 (en) * | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5354774A (en) * | 1992-12-24 | 1994-10-11 | Yale University | Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light |
US5279565A (en) * | 1993-02-03 | 1994-01-18 | Localmed, Inc. | Intravascular treatment apparatus and method |
US5788687A (en) * | 1994-02-01 | 1998-08-04 | Caphco, Inc | Compositions and devices for controlled release of active ingredients |
US5788979A (en) * | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
US6306165B1 (en) * | 1996-09-13 | 2001-10-23 | Meadox Medicals | ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin |
US6245760B1 (en) * | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
CA2332314A1 (en) * | 1998-06-11 | 1999-12-16 | Cerus Corporation | Use of alkylating compounds for inhibiting proliferation of arterial smooth muscle cells |
WO2001060816A1 (en) * | 2000-02-17 | 2001-08-23 | Amgen Inc. | Kinase inhibitors |
WO2002045717A1 (en) * | 2000-12-06 | 2002-06-13 | Tularik Inc. | Lometrexol combination therapy |
US6872715B2 (en) * | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
-
2002
- 2002-10-25 NZ NZ532593A patent/NZ532593A/en unknown
- 2002-10-25 WO PCT/US2002/034344 patent/WO2003034938A2/en active Application Filing
- 2002-10-25 BR BRPI0213497-7A patent/BR0213497A/pt not_active IP Right Cessation
- 2002-10-25 US US10/280,576 patent/US20040044405A1/en not_active Abandoned
- 2002-10-25 EP EP02784295A patent/EP1441749A4/en not_active Withdrawn
- 2002-10-25 PL PL02374315A patent/PL374315A1/xx not_active Application Discontinuation
- 2002-10-25 HU HU0402036A patent/HUP0402036A3/hu unknown
- 2002-10-25 CN CNA028211502A patent/CN1635858A/zh active Pending
- 2002-10-25 RU RU2004116068/14A patent/RU2004116068A/ru not_active Application Discontinuation
- 2002-10-25 MX MXPA04003906A patent/MXPA04003906A/es not_active Application Discontinuation
- 2002-10-25 JP JP2003537510A patent/JP2006519623A/ja active Pending
- 2002-10-25 IL IL16158302A patent/IL161583A0/xx unknown
- 2002-10-25 CA CA002464093A patent/CA2464093A1/en not_active Abandoned
- 2002-10-25 KR KR10-2004-7006059A patent/KR20040051618A/ko not_active Application Discontinuation
-
2004
- 2004-04-23 EC EC2004005085A patent/ECSP045085A/es unknown
- 2004-04-28 ZA ZA200403184A patent/ZA200403184B/en unknown
- 2004-05-24 NO NO20042133A patent/NO20042133L/no not_active Application Discontinuation
- 2004-05-25 CO CO04048129A patent/CO5580792A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006519623A (ja) | 2006-08-31 |
IL161583A0 (en) | 2004-09-27 |
HUP0402036A3 (en) | 2008-04-28 |
MXPA04003906A (es) | 2005-02-17 |
WO2003034938A2 (en) | 2003-05-01 |
CO5580792A2 (es) | 2005-11-30 |
PL374315A1 (en) | 2005-10-03 |
ZA200403184B (en) | 2005-05-12 |
BR0213497A (pt) | 2006-05-23 |
ECSP045085A (es) | 2004-07-23 |
US20040044405A1 (en) | 2004-03-04 |
CN1635858A (zh) | 2005-07-06 |
CA2464093A1 (en) | 2003-05-01 |
EP1441749A2 (en) | 2004-08-04 |
WO2003034938A3 (en) | 2003-11-13 |
KR20040051618A (ko) | 2004-06-18 |
RU2004116068A (ru) | 2005-03-20 |
NZ532593A (en) | 2007-11-30 |
NO20042133L (no) | 2004-07-09 |
EP1441749A4 (en) | 2010-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402036A2 (hu) | Protein tirozin-kináz inhibitorokkal bevont vagy impregnált vaszkuláris stent vagy graft és eljárás alkalmazására | |
Begovac et al. | Improvements in GORE-TEX® Vascular Graft performance by Carmeda® bioactive surface heparin immobilization | |
Indolfi et al. | Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats | |
WO2004075781A3 (en) | Bioactive stents and methods for use thereof | |
Freeman et al. | A link between stent radial forces and vascular wall remodeling: the discovery of an optimal stent radial force for minimal vessel restenosis | |
WO2004060318A3 (en) | Drug-coated stents and methods of use therefor | |
DE69827192D1 (de) | Stent und Stent-Transplantat zur Behandlung von verzweigten Blutgefässen | |
WO2006063158A3 (en) | Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles | |
DK1063945T3 (da) | Tvedelt prostetisk graft | |
DE69632310D1 (de) | Therapeutische inhibitoren der zellen der glatten gefässmuskulatur | |
EP1214057A4 (en) | COMPOSITION FOR VESSEL COATING | |
AU2001285059A1 (en) | Coated vascular grafts and methods of use | |
WO2006020742A3 (en) | Medical devices having nanoporous layers and methods for making the same | |
DE69942954D1 (de) | Endovaskuläre behandlung chronischer venöser insuffizienz | |
NO20063593L (no) | Stentimplantat med bioaktive belegg | |
ATE464025T1 (de) | Herstellungsverfahren für medizinprodukte mit nanoporösen schichten | |
ATE478629T1 (de) | Verbundene beinverlängerungen für eine endoluminal-prothese | |
PT1126870E (pt) | Utilizacao do gene vegf-c ou vegf-d ou de uma proteina na prevencao da restenose | |
ATE438361T1 (de) | Stent beschichtet mit dna | |
MXPA05011620A (es) | Dispositivos medicos y metodos para inhibir la proliferacion de celulas de musculo liso. | |
EP1600122A3 (en) | Methods and apparatus for treatment of aneurysmal tissue | |
NO20030579L (no) | Vaskulaere grafter og fremgangsmater til implantering derav | |
AU2003216517A8 (en) | Iliac bifurcation balloon catheter | |
DE60037032D1 (de) | Anwendung von pdt zur inhibierung von hyperplasie der intima | |
WO2003059192A3 (en) | C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |